| Dr Vidya Pradhan Phoenix, MD | |
|
2700 Highway 34 East, Bldg 300, Newnan, GA 30265-2315 | |
| (678) 423-7700 | |
| (678) 423-7710 |
| Full Name | Dr Vidya Pradhan Phoenix |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 2700 Highway 34 East, Newnan, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972722791 | NPI | - | NPPES |
| 590932462I | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 059853 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thomas Eye Group Pc | 2567455868 | 44 |
News Archive
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
Today's early morning highlights from major news organizations look at a probe of a California hospital chain, the effect that the governors' races around the country will have on the federal health law and a review of prescription purchases that shows more Americans are foregoing their medicines.
Today, the House of Representatives passed the Stupak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and Lipinski amendment to the "Affordable Health Care for America Act" (H.R. 3962). The amendment maintains the current policy of preventing federal funding for abortion and for benefits packages that include abortion.
BIOTRONIK AG, a European manufacturer of therapy solutions for vascular intervention, has announced the international full market release of the innovative Pulsar-18 stent for treatment of long lesions in the superficial femoral and infrapopliteal arteries. Pulsar-18 is unique in the market, representing an advance in technology that further reinforces the company's position as a leader in providing high quality technologies for patients with peripheral vascular disease.
A team of researchers led by an NIBIB grantee at Vanderbilt University has created a biodegradable scaffold that enables sustained, local delivery of gene-silencing factors called siRNA to promote tissue regeneration. The team recently used the scaffold to successfully deliver siRNA to mice in order to locally silence a gene normally responsible for inhibiting blood vessel formation.
› Verified 8 days ago
| Entity Name | Thomas Eye Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548271992 PECOS PAC ID: 2567455868 Enrollment ID: O20040405000273 |
News Archive
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
Today's early morning highlights from major news organizations look at a probe of a California hospital chain, the effect that the governors' races around the country will have on the federal health law and a review of prescription purchases that shows more Americans are foregoing their medicines.
Today, the House of Representatives passed the Stupak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and Lipinski amendment to the "Affordable Health Care for America Act" (H.R. 3962). The amendment maintains the current policy of preventing federal funding for abortion and for benefits packages that include abortion.
BIOTRONIK AG, a European manufacturer of therapy solutions for vascular intervention, has announced the international full market release of the innovative Pulsar-18 stent for treatment of long lesions in the superficial femoral and infrapopliteal arteries. Pulsar-18 is unique in the market, representing an advance in technology that further reinforces the company's position as a leader in providing high quality technologies for patients with peripheral vascular disease.
A team of researchers led by an NIBIB grantee at Vanderbilt University has created a biodegradable scaffold that enables sustained, local delivery of gene-silencing factors called siRNA to promote tissue regeneration. The team recently used the scaffold to successfully deliver siRNA to mice in order to locally silence a gene normally responsible for inhibiting blood vessel formation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vidya Pradhan Phoenix, MD 5901a Peachtree Dunwoody Rd, Ste 500, Atlanta, GA 30328-7162 Ph: (678) 781-7373 | Dr Vidya Pradhan Phoenix, MD 2700 Highway 34 East, Bldg 300, Newnan, GA 30265-2315 Ph: (678) 423-7700 |
News Archive
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
Today's early morning highlights from major news organizations look at a probe of a California hospital chain, the effect that the governors' races around the country will have on the federal health law and a review of prescription purchases that shows more Americans are foregoing their medicines.
Today, the House of Representatives passed the Stupak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and Lipinski amendment to the "Affordable Health Care for America Act" (H.R. 3962). The amendment maintains the current policy of preventing federal funding for abortion and for benefits packages that include abortion.
BIOTRONIK AG, a European manufacturer of therapy solutions for vascular intervention, has announced the international full market release of the innovative Pulsar-18 stent for treatment of long lesions in the superficial femoral and infrapopliteal arteries. Pulsar-18 is unique in the market, representing an advance in technology that further reinforces the company's position as a leader in providing high quality technologies for patients with peripheral vascular disease.
A team of researchers led by an NIBIB grantee at Vanderbilt University has created a biodegradable scaffold that enables sustained, local delivery of gene-silencing factors called siRNA to promote tissue regeneration. The team recently used the scaffold to successfully deliver siRNA to mice in order to locally silence a gene normally responsible for inhibiting blood vessel formation.
› Verified 8 days ago
Jackson T. Giles, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 15 Cavender St, Newnan, GA 30263 Phone: 770-253-6616 | |
Mr. Jay Steven Berger, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 58 Hospital Road, Suite 203, Newnan, GA 30263 Phone: 770-253-9900 Fax: 770-253-7351 | |
Suketu J Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2700 Highway 34 E Ste 100, Newnan, GA 30265 Phone: 678-423-7700 Fax: 678-423-7710 | |
Dr. Ninita Helen Brown, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2700 Hwy 34 East Bldg 300, Newnan, GA 30265 Phone: 678-423-7700 Fax: 678-423-7710 |